212
Participants
Start Date
October 31, 1999
Primary Completion Date
April 30, 2009
Study Completion Date
May 31, 2009
Baerveldt implant
Patients will be randomized to receive a 350 mm\^2 Baerveldt glaucoma implant or a Trabeculectomy (guarded filtration surgery) with mitomycin C (0.4 mg/ml for 4 minutes)
Trabeculectomy with mitomycin C
Patients will be randomized to receive either a Trabeculectomy (guarded filtration surgery) with mitomycin C (0.4 mg/ml for 4 minutes) or a 350 mm\^2 Baerveldt glaucoma implant
New York Eye and Ear Infirmary, New York
University of Virginia, Charlottesville
Duke University, Durham
Medical University of South Carolina, Charleston
University of Florida, Gainesville
Bascom Palmer Eye Institute, Miami
Indiana University, Indianapolis
Medical College of Wisconsin, Milwaukee
University of Wisconsin, Madison
Loyola University, Maywood
St. Louis University, St Louis
University of Oklahoma, Oklahoma City
University of Texas Houston, Houston
University of Southern California, Los Angeles
Scripps Clinic, La Jolla
University of California Davis, Sacramento
Moorfields Eye Hospital, London
Collaborators (1)
Pfizer
INDUSTRY
Abbott Medical Optics
INDUSTRY
University of Miami
OTHER